CDMO Dossier

CDMO research corrections and open questions

New facility reads document AGC Seattle equipment, Holly Springs mammalian mAbs and the Costa Mesa/Tustin distinction. Read the sources. Remaining items: protein-specific scope at Samsung Rockville; commercial manufacturing scope at Avid Costa Mesa; AGC Seattle’s specific branded 6Pack configuration (the new facility page does document nine 2,000 L vessels); current post-2024 operations at Catalent Madison/Bloomington (April 13, 2021 disclosure); Thermo Fisher Patheon site-level capacity mapping; Societal CDMO redirect verification; US sponsor procurement / BIOSECURE applicability (editorial question; unknown in saved vendor pages); facility-linked FDA Form 483 / inspection records; current slot availability; commercial pricing.